Precigen (PGEN) Net Cash Flow (2012 - 2026)
Precigen's (PGEN) quarterly Net Cash Flow came in at -$22.8 million in Q1 2026, up 3.03% year-on-year from -$22.1 million in Q1 2025, and down 243.16% on a QoQ basis from $15.9 million in Q4 2025.
Precigen (PGEN) Net Cash Flow (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Net Cash Flow data on file, last reported at -$22.8 million in Q1 2026.
- On a quarterly basis, Net Cash Flow rose 3.03% year-over-year to -$22.8 million in Q1 2026; TTM through Mar 2026 was $1.4 million, a 111.88% increase from a year earlier, with the FY2025 full-year figure at $682000.0, down 96.86% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$22.8 million, down from $15.9 million in the prior quarter.
- Over the last five years, Net Cash Flow for PGEN reached as high as $42.3 million in Q3 2022 and fell as low as -$43.3 million in Q4 2022.
- Historically, Net Cash Flow has averaged -$2.0 million across 5 years, with a median of -$2.4 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 709.72% in 2022 and fell as far as 3616.83% in 2022.
- Year by year, Net Cash Flow stood at -$43.3 million in 2022, then soared by 94.28% to -$2.5 million in 2023, then soared by 293.85% to $4.8 million in 2024, then jumped by 231.5% to $15.9 million in 2025, then plunged by 243.16% to -$22.8 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$22.8 million in Q1 2026, $15.9 million in Q4 2025, and $552000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | -22.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.75 Mn |
| Mar 31, 2026 | -22.75 Mn |
| Dec 31, 2025 | 15.89 Mn |
| Dec 31, 2025 | 15.89 Mn |
| Sep 30, 2025 | 552,000.00 |
| Sep 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 7.70 Mn |
| Jun 30, 2025 | 7.70 Mn |
| Mar 31, 2025 | -23.46 Mn |
| Mar 31, 2025 | -23.46 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Dec 31, 2024 | 4.79 Mn |
| Sep 30, 2024 | 15.05 Mn |
| Sep 30, 2024 | 15.05 Mn |
| Jun 30, 2024 | -8.10 Mn |
| Jun 30, 2024 | -8.10 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Dec 31, 2023 | -2.47 Mn |